Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06468618 · ClinicalTrials.gov registry record · NA
Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
A NA study of Sleep Disturbance and Stem Cell Transplant Complications, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT06468618 is a NA study of Sleep Disturbance and Stem Cell Transplant Complications that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 10 participants, below the 178-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06468618, a NA study of Sleep Disturbance and Stem Cell Transplant Complications, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
Pediatric patients undergoing stem cell transplant (SCT) are hospitalized for extended periods and are at high risk for sleep disturbances. In order to begin to address the environmental issues that SCT recipients face during inpatient hospitalizations, investigators will conduct a single arm pilot study of a program entitled 'Developing Restful Environments and Management Strategies' (DREAMS). The program will provide children receiving SCT and families with information and a kit that includes tools which may support sleep and circadian health during an inpatient hospitalization.
Conditions Studied
Interventions
- BEHAVIORAL DREAMS Program Video and Care Kit
Study Locations (2)
Massachusetts
- Boston Children's Hospital - Boston
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-08-06 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06468618
The ClinicalTrials.gov registry entry for NCT06468618 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (94% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sleep Disturbance appearing as the primary indexed condition, and to 1 intervention - of which DREAMS Program Video and Care Kit is the first listed.
NCT06468618 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06468618 about?
NCT06468618 is a clinical study titled "Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients". Pediatric patients undergoing stem cell transplant (SCT) are hospitalized for extended periods and are at high risk for sleep disturbances. In order to begin to address the environmental issues that SCT recipients face during inpatient hospitalizations, investigators will conduct a single arm pilot ...
What is the current status of trial NCT06468618?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-08-06. Estimated completion is 2026-08.
What conditions does trial NCT06468618 study?
This clinical trial studies the following conditions: Sleep Disturbance, Stem Cell Transplant Complications.
What interventions are being tested in trial NCT06468618?
The interventions under investigation include: DREAMS Program Video and Care Kit (BEHAVIORAL).
Who is sponsoring clinical trial NCT06468618?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06468618 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disturbance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adjunctive Bright Light Therapy for Opioid Use Disorder
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia
RECRUITING · NA
-
Sleep Promotion Program Primary Care
RECRUITING · NA
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
-
SPARK Healthy Sleep
RECRUITING · NA
Explore more on PlainTrial
Sleep Disturbance
All registered trials for this condition
Stem Cell Transplant Complications
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.